Dana Farber Cancer Institute

Photo Credit: MassBio

By Laura Lovett 04:13 pm September 10, 2019
Startups can have a difficult time striking a balance between the fast pace of tech culture and healthcare’s slow-and-steady validation culture. In part, the culture clash is a West Coast-East Coast divide, with tech giants congregating for the most part in California and hospitals and pharma in the Northeast, according to a panel moderated by CNBC’s Christina Farr at the MassBio Digital Health...
By Jonah Comstock 08:22 am June 28, 2019
One easy mistake for an organization to make is to think of innovation as a project that can be finished. Certainly healthcare systems have seen success with large-scale transformation projects with set end dates that can be said to be concluded. But the nature of innovation is that it’s ongoing, not just because technology is always advancing, but also because the needs of patients and providers...
By Laura Lovett 03:20 pm March 29, 2018
With artificial intelligence and augmented reality popping up around every corner in healthcare, players in the industry are beginning to reflect on how tech innovation in healthcare works, where it works, and whether these technologies themselves actually work.  At The Economist’s Healthcare Forum in Cambridge, Massachusetts this week, experts sat down to talk about the future of healthcare...
By Aditi Pai 01:28 pm April 27, 2016
Dana Farber Cancer Institute has partnered with Fitbit to launch a two-year randomized study that will investigate the impact of weight loss on breast cancer recurrence. The study, called the Breast Cancer Weight Loss (BWEL) study, is sponsored by the National Cancer Institute and the Alliance for Clinical Trials in Oncology. “The increased risk of cancer recurrence linked to excess body weight...